Home > Report Listing > Global Drug Discovery Informatics Market to reach USD 4.42 billion by 2026
MedicalDevices
Global Drug Discovery Informatics Market to reach USD 4.42 billion by 2026
Drug Discovery Informatics Report provides a comprehensive glance on a global and regional level. The study provides historical data from 2016 to 2018 along with a forecast from 2019 to 2026 based on revenue (USD Billion).
54
Global Drug Discovery Informatics Market is valued approximately USD 1.89 billion in 2018 and is anticipated to grow with a healthy growth rate of more than 11.20% over the forecast period 2019-2026. Drug discovery informatics is a functional process performed by biotechnology and pharmaceutical companies that requires the generation of very large data and information. Through application of modern engineering and computational approaches the models are analyzed, visualized and simulated for pharmacological profiling. Further, rising R&D expenditure on pharmaceuticals along with the increasing government focus on drug discovery are some key forces, driving the growth of the drug discovery informatics market over the forecast period of 2019-2026. For instance: According to the U.K. government in 2016, drug development sector and continuous manufacturing would receive funds around USD 82.5 million from government and private sources as part of its new USD 188 million effort and ?Industry Strategy? to establish six key research hubs in UK to boost research and development activities related to drug discovery. As a result, the adoption of the drug discovery informatics would increase thereby, contributing towards the growth of the market. However, high pricing and set up cost of informatics software impede the growth of the global drug discover informatics market. The regional analysis of global drug discovery informatics market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to well-established healthcare infrastructure along with the presence of various biotechnology and drug companies. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2019-2026 due to availability of low cost of human resources and manufacturing and availability of many qualified researchers. Also, the growth of the Asia-Pacific region is attributed owing to the ongoing drug development activities undertaken by government. Major market player included in this report are: Jubilant Life Sciences IBM Infosys Thermo Fisher Scientific Perkinelmer Schr?dinger Dassault Syst?mes Charles River Laboratories GVK Biosciences Boehringer Ingelheim GmbH The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below: By Function: Sequencing & Target Data Analysis Docking Molecular Modelling Libraries & Database Preparation Other Functions By Solution: Software Services By End-User: Pharmaceutical and Biotechnology Companies Contract Research Organizations (CROS) Others End Users By Regions: North America U.S. Canada Europe UK Germany Asia Pacific China India Japan Latin America Brazil Mexico Rest of the World Furthermore, years considered for the study are as follows: Historical year ? 2016, 2017 Base year ? 2018 Forecast period ? 2019 to 2026 Target Audience of the Global Drug Discovery Informatics Market in Market Study: Key Consulting Companies & Advisors Large, medium-sized, and small enterprises Venture capitalists Value-Added Resellers (VARs) Third-party knowledge providers Investment bankers Investors
Note: Kindly note sample report does not include any data or related information of the research study. It only showcase flow of information and different section covered. It is a paid report
01
Project Kick-off
Getting the research team on board discussing research objective, research scope, methodology, timeline and challenges
02
Desk Research
Developing Contact lits,Questionnaires,and market models Conducting desk research through credible publishedsources to collect relevant qualitative & quantitative data in relation to the research objectives
03
Primary Research
Conducting interviews with key opinion leaders ( KOLs ) and stakeholders to derve data in relationto the research objective and validate market numbers estimated through market models and industry-leading research tool
04
Analysis & Report Writing
Analysing the data sourced via desk and primary research and building report, conclusions,& recommendations sed on research objective
Industry Research Insights follows a robust research methodology that involves data triangulation based on top-down, bottom-up approaches, and validation of the estimated market numbers through primary research. The information used to estimate the market size and forecast for various segments at the global, regional, and country level is derived from the most credible published sources and through interviews with the right stakeholders.
Growth rate or CAGR exhibited by a market for a certain forecast period is calculated on the basis of various factors and their level of impact on the market. These factors include market drivers, restraints, industry challenges, market and technological developments, market trends, etc.
Annual reports, investor presentation, SEC filings, and press releases of companies operating in the market
Studies published by relevant associations MedTech Europe; American College of Radiology; Cancer Council Australia; Japan Hospital Association, etc.), government sources (Centers for Disease Control & Prevention, Ministry of Health, Labour & Welfare, Japan; National Health Service, England, etc.), international organizations (World Health Organization, The Organization for Economic Co-operation and Development, Eurostat, etc.), and articles published by Research Gate, NCBI, etc.
Website, reports, and press releases of end user facilities – Hospitals, Ambulatory Surgery Centres, Clinics
Industry journals and paid databases
Details such as revenues, market share, strategies, growth rate, product & their pricing by region/country for all major companies
Details in relation to prevalence, incidence, patient numbers, distribution of patients, average price of treatment, etc.
Number of end user facilities by region/country and average annual spending or procurement of devices by type of end user facility
Number of procedures and average price of procedures
Replacement rate and pricing of capital equipment
Market dynamics in relation to the market under focus – Drivers, restraints, trends, and opportunities
Market & technological trends, new product developments, product pipeline.
Detailed product mappping of all Major and small players operating in the market
Estimmation of revenues/market size of all segments to arrive at the total market
Estimmates based on prevalence of diseases,diagnosed and treated patients numbers, product demand, and average annual spending on treatment
Estimates based on number of users end average consumption/spending by end users
Estimates based on number of procedures and average number of devices\consumables used per procedure
Top-down approach based on the data published on revenues, market share and growth rate of major players operating in the market
Discussions with key opinion leaders(KOLs) and stakeholders to validates market estimates and get their insights in relation to trends, dyanamics and competitive analysis
Key stakeholders such as purchasing managers, nurses, pharmacists, surgeons, physicians, etc. in end-use facilities such as hospitals, clinics, ambulatory surgery centers, pharmacies, research institutes, etc.
Key opinion leaders in related associations
Key stakeholders such as C-level executives, marketing managers, product managers, sales managers, etc. in major companies (suppliers and distributors) operating in the market
Insights from supply side respondents in relation to the market size, growth rate, market distribution, market dynamics, and market share analysis
Validation of the market size, growth rate, and market distribution estimated on the basis of market models
nsights from end user respondents to feed into models such as patient/procedure numbers, distribution of patients by treatment type, average pricing, average spending on devices, replacement rate of capital equipment, etc.
Jubilant Life Sciences IBM Infosys Thermo Fisher Scientific Perkinelmer Schr?dinger Dassault Syst?mes Charles River Laboratories GVK Biosciences Boehringer Ingelheim GmbH
Review
Industry & Research is a safe and trustful bridge which connect clients to data, insights and market research professionals, to achieve reliable results.
3M
I&R did an outstanding job on the Global Automotive Catalyst Market project. We were extremely impressed by the simple but comprehensive presentation of the study and the quality of work done. This report really helped us to access untapped opportunities across the globe.
Leading Chemical industry-France
The information in the 'Military Aircraft Health Monitoring System' study was very well appreciated. The customer centric and friendly approach by such a large market research firm is what differentiates you from your competitors
Leading Defense Industry-Privacy Requested
Our Clients
2019-07-10
Our team of researchers are studying COVID 19 and its impact on various industry verticals and wherever required we will be considering COVID-19 footprints for better analysis of markets and industries.